Compare VanEck Vietnam ETF (VNM) vs DENTSPLY SIRONA Inc (XRAY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
VanEck Vietnam ETF vs DENTSPLY SIRONA Inc — how do they compare? VanEck Vietnam ETF trades at $17.88, while DENTSPLY SIRONA Inc trades at $10.68 (market cap $2.19B). The key difference: DENTSPLY SIRONA Inc pays a 5.04% dividend while VanEck Vietnam ETF pays none, and VanEck Vietnam ETF is trading nearer its 52-week high, DENTSPLY SIRONA Inc nearer its low. Which is the better fit depends on your goals.
| VNM | XRAY | |
|---|---|---|
Sector | Sector/Thematic | Health |
52-Week High | $19.80 | $14.68 |
52-Week Low | $16.34 | $9.64 |
Market Cap | — | $2.19B |
Enterprise Value | — | $4.26B |
Dividend Yield | — | 5.04% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
VNM trades at $17.91, down 1.38% for the day, with a technical outlook leaning bearish based on moving averages. The ETF's performance is challenged by its heavy concentration in Vietnamese real estate and financials, exposing it to sector-specific volatility. Recent news highlights underperformance relative to other emerging markets, though potential exists from FTSE Russell's upcoming EM reclassification in September 2026, which may attract foreign institutional flows.
The outlook remains cautious due to near-term headwinds from sector concentration and macroeconomic factors in Vietnam. Investment opportunity hinges on the country's long-term growth trajectory and potential inflows from index changes, but risks from interest rate sensitivity and concentrated holdings warrant careful consideration for investors seeking emerging market exposure.
XRAY trades at $10.99, down 3.43% on the day, reflecting ongoing challenges amid a bearish technical signal. The company reported a Q2 2026 earnings beat but faces declining revenue and negative profitability, with a net income margin of -14.99%. Cash flow trends show volatility, and the debt-to-asset ratio has worsened to 42.88% in 2025. Recent news highlights margin pressure and a class-action lawsuit inquiry, clouding the near-term outlook despite some institutional buying interest.
The investment outlook is cautious. While the stock trades below the consensus price target of $12.50, persistent net losses, high debt, and competitive pressures pose significant risks. Analyst sentiment is mixed with a 'Hold' consensus, suggesting limited upside until the company demonstrates sustained operational improvement and revenue stabilization.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About VanEck Vietnam ETF
VNM is the first and largest U.S.-listed ETF providing targeted exposure to the Vietnamese equity market. It tracks the MarketVector™ Vietnam Local Index, which includes publicly traded companies that are locally incorporated in Vietnam. It serves as a liquid, transparent vehicle for investors looking to participate in Vietnam's transition into a global manufacturing hub and its long-term potential for emerging market reclassification.
Read more on VNM →About DENTSPLY SIRONA Inc
Dentsply Sirona Inc is a global manufacturer and distributor of dental supplies and equipment. The company's operating segments include Technologies & Equipment, which is responsible for the design, manufacture, sales, and distribution of products including dental implants, CAD/CAM systems, orthodontic clear aligner products, imaging systems, treatment centers, instruments, as well as certain healthcare device products, primarily catheters
Read more on XRAY →
